• 1
    Bauer TM, Schwacha H, Steinbruckner B et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol 2002; 97:236470.
  • 2
    Von Baehr V, Docke WD, Plauth M et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000; 47:2817.
  • 3
    Guarner C, Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Eur J Gastroenterol Hepatol 2005; 17:2731.
  • 4
    Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300:15245.
  • 5
    Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783801.
  • 6
    Hoffmann A, Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006; 210:17186.
  • 7
    Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:88591.
  • 8
    Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:114.
  • 9
    Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:7405.
  • 10
    Nakao Y, Funami K, Kikkawa S et al. TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J Immunol 2005; 174:156673.
  • 11
    Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 2003; 101:45004.
  • 12
    Hornung V, Rothenfusser S, Britsch S et al. Quantitative expression of Toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:45317.
  • 13
    Hanten JA, Vasilakos JP, Riter CL et al. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol 2008; 9:39.
  • 14
    Poeck H, Wagner M, Battiany J et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 2004; 103:305864.
  • 15
    Liu N, Ohnishi N, Ni L, Akira S, Bacon KB. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 2003; 4:68793.
  • 16
    He B, Qiao X, Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004; 173:447991.
  • 17
    Blaas SH, Stieber-Gunckel M, Falk W, Obermeier F, Rogler G. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clin Exp Immunol 2009; 155:53440.
  • 18
    Kikuchi K, Lian ZX, Yang GX et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005; 128:30412.
  • 19
    Such J, Frances R, Munoz C et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 2002; 36:13541.
  • 20
    Glaum MC, Narula S, Song D et al. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production. J Allergy Clin Immunol 2009; 123:22430, e4.
  • 21
    Meiler F, Klunker S, Zimmermann M, Akdis CA, Akdis M. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and Toll-like receptors. Allergy 2008; 63:145563.
  • 22
    Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438:3648.
  • 23
    Albillos A, De La Hera A, Gonzalez M et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37:20817.
  • 24
    Iimuro Y, Gallucci RM, Luster MI, Kono H, Thurman RG. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997; 26:15307.
  • 25
    McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol 2002; 27:5361.
  • 26
    Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Deviere J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholic cirrhosis. Hepatology 1995; 22:14369.
  • 27
    Deviere J, Content J, Denys C et al. Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: a study of normal subjects and alcoholic cirrhotics. Gastroenterology 1992; 103:1296301.
  • 28
    Riordan SM, Skinner N, Nagree A et al. Peripheral blood mononuclear cell expression of Toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003; 37:115464.
  • 29
    Van De Wiel A, Schuurman HJ, Kater L. Alcoholic liver disease: an IgA-associated disorder. Scand J Gastroenterol 1987; 22:102530.
  • 30
    Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331:11228.
  • 31
    Silvain C, Patry C, Launay P, Lehuen A, Monteiro RC. Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma. J Immunol 1995; 155:160618.
  • 32
    Nouri-Aria KT, Alexander GJ, Portmann BC, Hegarty JE, Eddleston AL, Williams R. T and B cell function in alcoholic liver disease. J Hepatol 1986; 2:195207.
  • 33
    Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11:7559.
  • 34
    Freund J, Casals J, Hosmer E. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 1937; 37:50913.
  • 35
    Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98:923742.
  • 36
    Levan-Petit I, Lelievre E, Barra A et al. T(h)2 cytokine dependence of IgD production by normal human B cells. Int Immunol 1999; 11:181928.
  • 37
    Pene J, Gauchat JF, Lecart S et al. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J Immunol 2004; 172:51547.
  • 38
    Hayashi F, Means TK, Luster AD. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102:26609.
  • 39
    Vandesompele J, De Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT–PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034. Epub 18 June 2002.
  • 40
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 2001; 29:e45.